查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869687

煙醯胺腺嘌呤二核苷酸市場規模、佔有率和趨勢分析報告：按產品、分銷管道、地區和細分市場預測（2025-2033 年）

Nicotinamide Adenine Dinucleotide Products Market Size, Share & Trends Analysis Report By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10個工作天內

價格

煙醯胺腺嘌呤二核苷酸產品市場摘要

2024 年全球菸鹼醯胺腺嘌呤二核苷酸產品市場規模為 34.5116 億美元，預計到 2033 年將達到 121.8724 億美元。

預計從 2025 年到 2033 年，煙醯胺腺嘌呤二核苷酸 (NAD) 產品產業將以 15.1% 的複合年成長率成長。人們對 NAD 在細胞能量產生、DNA 修復和健康老齡化中的作用的認知不斷提高，推動了 NAD 產品產業的成長。

隨著人們對長壽和預防保健的日益關注，消費者正在尋求能夠增強活力、改善認知功能和促進代謝健康的營養補充品。此外，將NAD水平與老齡化相關疾病聯繫起來的持續研究也進一步推動了營養補充劑和健康市場的需求。

由於人們對健康老齡化和提升認知功能的興趣日益濃厚，像NR（菸鹼醯胺核苷）和NMN（菸鹼醯胺單核苷酸）這樣的NAD+補充劑越來越受歡迎。 Tru Niagen和Elysium Health等品牌抓住了這一趨勢，推出了聲稱可以增強精力、提高注意力並幫助抵抗與老齡化相關的衰退的產品。

NAD產品的應用範圍已不再局限於膳食補充劑，而是開始廣泛應用於靜脈輸液、護膚和機能飲料等領域，逐漸被更廣泛的消費者所熟知和接受。隨著臨床研究的不斷深入和消費者需求的成長，NAD正成為蓬勃發展的健康和抗衰老領域的關鍵成分。例如，領先的代謝健康平台Eden於2025年5月開始透過遠端醫療服務在全美銷售其NAD+ 10%乳霜（需憑處方箋）。

NAD產品產業已遠遠超越了傳統的口服補充劑，各大品牌都在探索新的給藥方式，以提升功效、使用者體驗和市場吸引力。雖然含有菸鹼醯胺核苷（NR）和菸鹼醯胺單核苷酸（NMN）等前體的膠囊和片劑仍然是主流，但脂質體配方、緩釋片和舌下粉劑等新型製劑因其提高生物利用度的潛力而日益受到關注。這些創新不僅滿足了消費者對更有效給藥方式的需求，也有助於品牌在競爭激烈的市場中脫穎而出。

例如，2025年1月，Renue by Science推出了Renue Blue，這是一個專注於肌膚健康和延緩衰老的全新護膚系列，採用脂質體包裹的NAD（煙醯胺腺嘌呤二核苷酸）。該產品系列旨在利用NAD（一種對細胞功能至關重要的輔酶）的益處，將其作為促進肌膚健康的局部外用成分。脂質體遞送系統旨在提高NAD在皮膚中的吸收率和功效。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場變數與趨勢

  • 市場發展
  • 產業價值鏈分析
    • 原料趨勢及展望
    • 零售/銷售管道分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機遇
    • 市場挑戰
  • 產業分析工具
    • 波特五力分析
  • 打入市場策略

4. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場：消費行為分析

  • 人口統計分析
  • 消費者趨勢和偏好
  • 影響購買決策的因素
  • 消費者產品採納
  • 觀察與建議

5. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場：按產品分類的估算和趨勢分析

  • 重點
  • 產品差異分析及市佔率（2024 年及 2033 年）
  • 按產品分類，2021-2033 年
    • 口服補充劑
    • 外用產品
    • 其他

6. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場：按分銷管道分類的估算和趨勢分析

  • 重點
  • 2024年及2033年通路變化分析及市場佔有率
  • 按分銷管道分類，2021-2033 年
    • 大賣場和超級市場
    • 藥房和藥品商店
    • 線上
    • 其他

7. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場：區域估算與趨勢分析

  • 2024年及2033年區域動態分析及市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲和紐西蘭
    • 台灣
    • 韓國
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 阿拉伯聯合大公國

8. 煙醯胺腺嘌呤二核苷酸 (NAD) 產品市場：競爭分析

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 參與企業概況
  • 財務業績
  • 產品基準測試
  • 公司市佔率分析，2024 年（%）
  • 企業熱力圖分析，2024 年
  • 策略規劃
  • 公司簡介
    • Core Med Science
    • Niagen Bioscience, Inc.
    • Elysium Health
    • Thorne
    • Cata-Kor NAD
    • Life Extension
    • Wonderfeel
    • Nutricost
    • RENUE BY SCIENCE, Inc.
    • Codeage LLC
    • HPN SUPPLEMENTS
Product Code: GVR-4-68040-787-5

Nicotinamide Adenine Dinucleotide Products Market Summary

The global nicotinamide adenine dinucleotide products market size was valued at USD 3,451.16 million in 2024 and is expected to reach USD 12,187.24 million by 2033, growing at a CAGR of 15.1% from 2025 to 2033. The nicotinamide adenine dinucleotide (NAD) products industry is driven by increasing awareness of its role in cellular energy production, DNA repair, and healthy aging.

Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. Additionally, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets.

The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.

NAD products are also seeing wider use beyond supplements, appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service.

The NAD products industry is expanding well beyond traditional oral supplements, with brands exploring new delivery formats to improve efficacy, user experience, and market appeal. While capsules and tablets containing precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) remain the most common format, newer options such as liposomal formulations, sustained-release tablets, and sublingual powders are gaining popularity for their potential to enhance bioavailability. These innovations not only cater to consumer demand for more effective dosing but also allow brands to differentiate in a crowded market.

For instance, in January 2025, Renue by Science introduced a new skincare line called Renue Blue, which focuses on skin wellness and longevity through the use of liposomal NAD (Nicotinamide Adenine Dinucleotide). The product line aims to leverage the benefits of NAD, a coenzyme crucial for cellular functions, in a topical format to promote skin health. The liposomal delivery system is designed to enhance the absorption and effectiveness of NAD in the skin.

Nicotinamide Adenine Dinucleotide Products Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide products market report on the basis of product, distribution channel, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral Supplements
    • Capsules/Tablets
    • Powders
    • Energy Drinks
  • Topical Products
    • Creams & Serums
    • Eye Cream & Lip Balms
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hypermarkets & Supermarkets
  • Pharmacies & Drug Stores
  • Online
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Taiwan
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Materials & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Nicotinamide Adenine Dinucleotide (NAD) Products Market Variables and Trends

  • 3.1. Market Introduction
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Raw Material Trends & Outlook
    • 3.2.2. Retail/Sales Channel Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Consumer Behavior Analysis

  • 4.1. Demographic Analysis
  • 4.2. Consumer Trends & Preferences
  • 4.3. Factors Affecting Buying Decisions
  • 4.4. Consumer Product Adoption
  • 4.5. Observations & Recommendations

Chapter 5. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Product Estimates & Trend Analysis

  • 5.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Product: Key Takeaways
  • 5.2. Product Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Market Estimates & Forecasts by Product, 2021 - 2033 (USD Million)
    • 5.3.1. Oral Supplements
      • 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.1. Capsules/Tablets
          • 5.3.1.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.2. Powders
          • 5.3.1.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.3. Energy Drinks
          • 5.3.1.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.2. Topical Products
      • 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.2.1.1. Creams & Serums
          • 5.3.2.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.2.1.2. Eye Cream & Lip Balms
          • 5.3.2.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Distribution Channel: Key Takeaways
  • 6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
    • 6.3.1. Hypermarkets & Supermarkets
      • 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.2. Pharmacies & Drug Stores
      • 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.3. Online
      • 6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.2. North America
    • 7.2.1. U.S.
      • 7.2.1.1. Key country dynamics
      • 7.2.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Key country dynamics
      • 7.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.3. Mexico
      • 7.2.3.1. Key country dynamics
      • 7.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. U.K.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Key country dynamics
      • 7.3.2.3.Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.3. France
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Key country dynamics
      • 7.3.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. China
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.2. India
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.4. Australia & New Zealand
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.5. Taiwan
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Brazil
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. UAE
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Competitive Analysis

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2024 (%)
  • 8.7. Company Heat Map Analysis, 2024
  • 8.8. Strategy Mapping
  • 8.9. Company Profiles
    • 8.9.1. Core Med Science
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Portfolios
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Niagen Bioscience, Inc.
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Portfolios
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. Elysium Health
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Portfolios
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. Thorne
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Portfolios
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. Cata-Kor NAD
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Portfolios
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. Life Extension
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Portfolios
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. Wonderfeel
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Portfolios
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. Nutricost
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Portfolios
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. RENUE BY SCIENCE, Inc.
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Portfolios
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. Codeage LLC
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Portfolios
      • 8.9.10.4. Strategic Initiatives
    • 8.9.11. HPN SUPPLEMENTS
      • 8.9.11.1. Company Overview
      • 8.9.11.2. Financial Performance
      • 8.9.11.3. Product Portfolios
      • 8.9.11.4. Strategic Initiatives

List of Tables

  • Table 1 Global nicotinamide adenine dinucleotide (NAD) products market - Key market driver analysis
  • Table 2 Global nicotinamide adenine dinucleotide (NAD) products market - Key market restraint analysis
  • Table 3 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by product (USD Million)
  • Table 4 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 5 U.S macro-economic outlay
  • Table 6 U.S nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 7 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 8 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 9 Canada macro-economic outlay
  • Table 10 Canada nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 11 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 12 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 13 Mexico macro-economic outlay
  • Table 14 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 15 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 16 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 17 U.K macro-economic outlay
  • Table 18 U.K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 19 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 20 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 21 Germany macro-economic outlay
  • Table 22 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 23 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 24 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 25 France macro-economic outlay
  • Table 26 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 27 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 28 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 29 Italy macro-economic outlay
  • Table 30 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 31 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 32 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 33 Spain macro-economic outlay
  • Table 34 Spain nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 35 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 36 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 37 China macro-economic outlay
  • Table 38 China nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 39 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 40 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 41 India macro-economic outlay
  • Table 42 India nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 43 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 44 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 45 Japan macro-economic outlay
  • Table 46 Japan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 47 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 48 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 49 Australia & New Zealand macro-economic outlay
  • Table 50 Australia & New Zealand Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 51 Taiwan macro-economic outlay
  • Table 52 Taiwan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 53 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 54 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 55 South Korea macro-economic outlay
  • Table 56 South Korea Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 57 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 58 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 59 Brazil macro-economic outlay
  • Table 60 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 61 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 62 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 63 UAE macro-economic outlay
  • Table 64 UAE nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 65 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 66 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 67 Recent developments & impact analysis by key market participants
  • Table 68 Company market share, 2024
  • Table 69 Company heat map analysis
  • Table 70 Companies undergoing key strategies

List of Figures

  • Fig. 1 Global Nicotinamide Adenine Dinucleotide (NAD) Products Market Segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 Market snapshot
  • Fig. 7 Product snapshot
  • Fig. 8 Distribution Channel snapshot
  • Fig. 9 Regional snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Global nicotinamide adenine dinucleotide (NAD) products market size (USD Million)
  • Fig. 12 Global nicotinamide adenine dinucleotide (NAD) products market size, 2021 to 2033 (USD Million)
  • Fig. 13 Global nicotinamide adenine dinucleotide (NAD) products market: Penetration & growth prospect mapping
  • Fig. 14 Global nicotinamide adenine dinucleotide (NAD) products market: Value chain analysis
  • Fig. 15 Global nicotinamide adenine dinucleotide (NAD) products market: Profit margin analysis
  • Fig. 16 Global nicotinamide adenine dinucleotide (NAD) products market: Market dynamics
  • Fig. 17 Global nicotinamide adenine dinucleotide (NAD) products market: Porter's five forces analysis
  • Fig. 18 Factors influencing buying decisions for nicotinamide adenine dinucleotide (NAD) products
  • Fig. 19 Global nicotinamide adenine dinucleotide (NAD) products market: Product Movement Analysis, 2024 & 2033 (%)
  • Fig. 20 Oral Supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Capsules/Tablets market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Powders market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Energy Drinks market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Topical Products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Creams & Serums market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Eye Cream & Lip Balms market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Global nicotinamide adenine dinucleotide (NAD) products market: Distribution Channel Movement Analysis, 2024 & 2033 (%)
  • Fig. 29 Hypermarkets & Supermarkets nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Pharmacies & Drug Stores nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Online nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Others nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Global nicotinamide adenine dinucleotide (NAD) products market: Regional outlook, 2024 & 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 U S market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Europe nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 U K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Spain nicotinamide adenine dinucleotide (NAD) products market estimates, 2021 - 2033 (USD Million)
  • Fig. 46 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 India market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Australia & New Zealand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Taiwan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key company categorization
  • Fig. 55 Company market share analysis, 2024
  • Fig. 56 Strategic framework of nicotinamide adenine dinucleotide (NAD) products market